These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
455 related articles for article (PubMed ID: 21424370)
1. A prospective study of total gastrectomy for CDH1-positive hereditary diffuse gastric cancer. Chen Y; Kingham K; Ford JM; Rosing J; Van Dam J; Jeffrey RB; Longacre TA; Chun N; Kurian A; Norton JA Ann Surg Oncol; 2011 Sep; 18(9):2594-8. PubMed ID: 21424370 [TBL] [Abstract][Full Text] [Related]
2. CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer. Norton JA; Ham CM; Van Dam J; Jeffrey RB; Longacre TA; Huntsman DG; Chun N; Kurian AW; Ford JM Ann Surg; 2007 Jun; 245(6):873-9. PubMed ID: 17522512 [TBL] [Abstract][Full Text] [Related]
3. Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications. Rogers WM; Dobo E; Norton JA; Van Dam J; Jeffrey RB; Huntsman DG; Kingham K; Chun N; Ford JM; Longacre TA Am J Surg Pathol; 2008 Jun; 32(6):799-809. PubMed ID: 18391748 [TBL] [Abstract][Full Text] [Related]
4. Germline mutation of the E-cadherin gene in three sibling cases with advanced gastric cancer: clinical consequences for the other family members. Mayrbaeurl B; Keller G; Schauer W; Burgstaller S; Czompo M; Hoebling W; Knoflach P; Duba HC; Hoefler H; Thaler J Eur J Gastroenterol Hepatol; 2010 Mar; 22(3):306-10. PubMed ID: 19474748 [TBL] [Abstract][Full Text] [Related]
5. [From gene to disease; E-cadherin and hereditary diffuse gastric cancer]. de Bruin JH; Ligtenberg MJ; Nagengast FM; van Krieken JH Ned Tijdschr Geneeskd; 2003 Dec; 147(50):2474-7. PubMed ID: 14708213 [TBL] [Abstract][Full Text] [Related]
6. Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations. Huntsman DG; Carneiro F; Lewis FR; MacLeod PM; Hayashi A; Monaghan KG; Maung R; Seruca R; Jackson CE; Caldas C N Engl J Med; 2001 Jun; 344(25):1904-9. PubMed ID: 11419427 [TBL] [Abstract][Full Text] [Related]
7. Histopathological and molecular analysis of gastrectomy specimens from hereditary diffuse gastric cancer patients has implications for endoscopic surveillance of individuals at risk. Barber ME; Save V; Carneiro F; Dwerryhouse S; Lao-Sirieix P; Hardwick RH; Caldas C; Fitzgerald RC J Pathol; 2008 Nov; 216(3):286-94. PubMed ID: 18825658 [TBL] [Abstract][Full Text] [Related]
9. Periodic acid-schiff is superior to hematoxylin and eosin for screening prophylactic gastrectomies from CDH1 mutation carriers. Lee AF; Rees H; Owen DA; Huntsman DG Am J Surg Pathol; 2010 Jul; 34(7):1007-13. PubMed ID: 20534996 [TBL] [Abstract][Full Text] [Related]
11. CDH1 associated gastric cancer: a report of a family and review of the literature. Moran CJ; Joyce M; McAnena OJ Eur J Surg Oncol; 2005 Apr; 31(3):259-64. PubMed ID: 15780560 [TBL] [Abstract][Full Text] [Related]
12. Hereditary diffuse gastric cancer: implications of genetic testing for screening and prophylactic surgery. Cisco RM; Ford JM; Norton JA Cancer; 2008 Oct; 113(7 Suppl):1850-6. PubMed ID: 18798546 [TBL] [Abstract][Full Text] [Related]
13. Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening. Carneiro F; Huntsman DG; Smyrk TC; Owen DA; Seruca R; Pharoah P; Caldas C; Sobrinho-Simões M J Pathol; 2004 Jun; 203(2):681-7. PubMed ID: 15141383 [TBL] [Abstract][Full Text] [Related]
14. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1. van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394 [TBL] [Abstract][Full Text] [Related]
15. No mucosal escape of signet-ring cell carcinoma for ten years in a patient with familial aggregation of gastric cancer. Tanis PJ; Ten Kate FJ; van Lanschot JJ J Surg Oncol; 2008 Mar; 97(3):294-6. PubMed ID: 18161866 [TBL] [Abstract][Full Text] [Related]
16. Prospective cohort study assessing outcomes of patients from families fulfilling criteria for hereditary diffuse gastric cancer undergoing endoscopic surveillance. Lim YC; di Pietro M; O'Donovan M; Richardson S; Debiram I; Dwerryhouse S; Hardwick RH; Tischkowitz M; Caldas C; Ragunath K; Fitzgerald RC Gastrointest Endosc; 2014 Jul; 80(1):78-87. PubMed ID: 24472763 [TBL] [Abstract][Full Text] [Related]
17. [18F]Fluoro-2-deoxy-D-glucose positron emission tomography detects gastric carcinoma in an early stage in an asymptomatic E-cadherin mutation carrier. van Kouwen MC; Drenth JP; Oyen WJ; de Bruin JH; Ligtenberg MJ; Bonenkamp JJ; van Krieken JH; Nagengast FM Clin Cancer Res; 2004 Oct; 10(19):6456-9. PubMed ID: 15475432 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic and prophylactic gastrectomy in a family with hereditary diffuse gastric cancer secondary to a CDH1 mutation: a case series. Gjyshi O; Vashi P; Seewald L; Kohan M; Abboud E; Fowler E; Suppiah R; Halabi H World J Surg Oncol; 2018 Jul; 16(1):143. PubMed ID: 30007404 [TBL] [Abstract][Full Text] [Related]
19. Pathological features of total gastrectomy specimens from asymptomatic hereditary diffuse gastric cancer patients and implications for clinical management. Rocha JP; Gullo I; Wen X; Devezas V; Baptista M; Oliveira C; Carneiro F Histopathology; 2018 Dec; 73(6):878-886. PubMed ID: 30014492 [TBL] [Abstract][Full Text] [Related]
20. [Case n(o) 6: Signet ring cell intramucosal carcinoma in hereditary diffuse gastric cancer with mutated CDH1 gene]. Svrcek M Ann Pathol; 2011 Oct; 31(5):381-4. PubMed ID: 21982246 [No Abstract] [Full Text] [Related] [Next] [New Search]